Therapies for Olfactory Dysfunction - an Update

Overview

Journal Curr Allergy Asthma Rep

Specialties Allergy & Immunology
Pulmonary Medicine

Date 2022 Jan 24

PMID 35072929

Authors

Aria Jafari

Eric H Holbrook

Affiliations

Soon will be listed here.

Abstract

Purpose Of Review: Olfactory dysfunction is a prevalent condition affecting 5-15% of the general population, with significant impact on quality of life. This review summarizes the most recent and relevant literature in the treatment of olfactory dysfunction.

Recent Findings: Current evidence supports the short-term use of topical corticosteroids and systemic therapy. These treatments may occur in conjunction with olfactory training, which is well supported by the literature. While there are several additional treatments currently under investigation, meaningful conclusions are not yet able to be made regarding their efficacy. The treatment of olfactory dysfunction is targeted at the suspected etiology when possible. After normal aging, chronic rhinosinusitis, post-infectious sequelae including as a result SARS-CoV-2 infection (COVID-19), and head trauma are the most common causes. Current evidence supports the short-term use of topical corticosteroids and systemic therapy. Several additional treatments are under investigation but recommendations for their use cannot currently be made.

Citing Articles

Psychiatric Explanations of Poor Oral Intake: A Clinically Focused Review.

Grace E, Heaney B, France A, Bruckel T, Oldham M J Acad Consult Liaison Psychiatry. 2024; 65(5):458-470.

PMID: 39222846 PMC: 11531996. DOI: 10.1016/j.jaclp.2024.08.006.

Integrating the patient's voice into the research agenda for treatment of chemosensory disorders.

Murphy C, Dalton P, Boateng K, Hunter S, Silberman P, Trachtman J Chem Senses. 2024; 49.

PMID: 38761171 PMC: 11154145. DOI: 10.1093/chemse/bjae020.

Long-term smell loss experiences after COVID-19: A qualitative study.

Alkanat H, Arslan S Health Expect. 2024; 27(2):e14018.

PMID: 38494992 PMC: 10945215. DOI: 10.1111/hex.14018.

Post-traumatic olfactory dysfunction: a scoping review of assessment and rehabilitation approaches.

De Luca R, Bonanno M, Rifici C, Quartarone A, Calabro R Front Neurol. 2023; 14:1193406.

PMID: 37521284 PMC: 10374209. DOI: 10.3389/fneur.2023.1193406.

Olfactory Dysfunction following COVID-19 and the Potential Benefits of Olfactory Training.

Alarfaj A, Aldrweesh A, Aldoughan A, Alarfaj S, Alabdulqader F, AlYahya K J Clin Med. 2023; 12(14).

PMID: 37510876 PMC: 10381506. DOI: 10.3390/jcm12144761.

References

Holbrook E, Coelho D . Cranial Nerve Stimulation for Olfaction (Cranial Nerve 1). Otolaryngol Clin North Am. 2019; 53(1):73-85. DOI: 10.1016/j.otc.2019.09.014. View

Langdon C, Lehrer E, Berenguer J, Laxe S, Alobid I, Quinto L . Olfactory Training in Post-Traumatic Smell Impairment: Mild Improvement in Threshold Performances: Results from a Randomized Controlled Trial. J Neurotrauma. 2018; 35(22):2641-2652. DOI: 10.1089/neu.2017.5230. View

Pinto J, Mehta N, DiTineo M, Wang J, Baroody F, Naclerio R . A randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis. Rhinology. 2010; 48(3):318-24. DOI: 10.4193/Rhino09.144. View

Yan C, Rathor A, Krook K, Ma Y, Rotella M, Dodd R . Effect of Omega-3 Supplementation in Patients With Smell Dysfunction Following Endoscopic Sellar and Parasellar Tumor Resection: A Multicenter Prospective Randomized Controlled Trial. Neurosurgery. 2020; 87(2):E91-E98. PMC: 7360874. DOI: 10.1093/neuros/nyz559. View

Bachert C, Han J, Desrosiers M, Hellings P, Amin N, Lee S . Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet. 2019; 394(10209):1638-1650. DOI: 10.1016/S0140-6736(19)31881-1. View

Nguyen T, Patel Z . Budesonide irrigation with olfactory training improves outcomes compared with olfactory training alone in patients with olfactory loss. Int Forum Allergy Rhinol. 2018; 8(9):977-981. DOI: 10.1002/alr.22140. View

Dai Q, Pang Z, Yu H . Recovery of Olfactory Function in Postviral Olfactory Dysfunction Patients after Acupuncture Treatment. Evid Based Complement Alternat Med. 2016; 2016:4986034. PMC: 4789421. DOI: 10.1155/2016/4986034. View

Nigwekar S, Weiser J, Kalim S, Xu D, Wibecan J, Dougherty S . Characterization and Correction of Olfactory Deficits in Kidney Disease. J Am Soc Nephrol. 2017; 28(11):3395-3403. PMC: 5661283. DOI: 10.1681/ASN.2016121308. View

Jiang R, Lu F, Liang K, Shiao J, Su M, Hsin C . Olfactory function in patients with chronic rhinosinusitis before and after functional endoscopic sinus surgery. Am J Rhinol. 2008; 22(4):445-8. DOI: 10.2500/ajr.2008.22.3195. View

10.

Rezaeian A . Effect of Intranasal Insulin on Olfactory Recovery in Patients with Hyposmia: A Randomized Clinical Trial. Otolaryngol Head Neck Surg. 2018; 158(6):1134-1139. DOI: 10.1177/0194599818764624. View

11.

Henkin R, Velicu I, Schmidt L . An open-label controlled trial of theophylline for treatment of patients with hyposmia. Am J Med Sci. 2009; 337(6):396-406. DOI: 10.1097/MAJ.0b013e3181914a97. View

12.

Banglawala S, Oyer S, Lohia S, Psaltis A, Soler Z, Schlosser R . Olfactory outcomes in chronic rhinosinusitis with nasal polyposis after medical treatments: a systematic review and meta-analysis. Int Forum Allergy Rhinol. 2014; 4(12):986-94. DOI: 10.1002/alr.21373. View

13.

Seys S, De Bont S, Fokkens W, Bachert C, Alobid I, Bernal-Sprekelsen M . Real-life assessment of chronic rhinosinusitis patients using mobile technology: The mySinusitisCoach project by EUFOREA. Allergy. 2020; 75(11):2867-2878. PMC: 7687134. DOI: 10.1111/all.14408. View

14.

Altundag A, Cayonu M, Kayabasoglu G, Salihoglu M, Tekeli H, Saglam O . Modified olfactory training in patients with postinfectious olfactory loss. Laryngoscope. 2015; 125(8):1763-6. DOI: 10.1002/lary.25245. View

15.

Pellegrino R, Han P, Reither N, Hummel T . Effectiveness of olfactory training on different severities of posttraumatic loss of smell. Laryngoscope. 2019; 129(8):1737-1743. DOI: 10.1002/lary.27832. View

16.

Hummel T, Rissom K, Reden J, Hahner A, Weidenbecher M, Huttenbrink K . Effects of olfactory training in patients with olfactory loss. Laryngoscope. 2009; 119(3):496-9. DOI: 10.1002/lary.20101. View

17.

Mullol J, Bachert C, Amin N, Desrosiers M, Hellings P, Han J . Olfactory Outcomes With Dupilumab in Chronic Rhinosinusitis With Nasal Polyps. J Allergy Clin Immunol Pract. 2021; 10(4):1086-1095.e5. DOI: 10.1016/j.jaip.2021.09.037. View

18.

Morrissey D, Pratap U, Brown C, Wormald P . The role of surgery in the management of phantosmia. Laryngoscope. 2015; 126(3):575-8. DOI: 10.1002/lary.25647. View

19.

Whitcroft K, Ezzat M, Cuevas M, Andrews P, Hummel T . The effect of intranasal sodium citrate on olfaction in post-infectious loss: results from a prospective, placebo-controlled trial in 49 patients. Clin Otolaryngol. 2016; 42(3):557-563. DOI: 10.1111/coa.12789. View

20.

Schriever V, Merkonidis C, Gupta N, Hummel C, Hummel T . Treatment of smell loss with systemic methylprednisolone. Rhinology. 2012; 50(3):284-9. DOI: 10.4193/Rhino.11.207. View